Join Now | Print Page | Contact Us
Registration 2022

 ABOUT THE MEETING

The CCOI executive committee and working group leaders invite you to view the recordings of this second meeting of the Collaborative Community on Ophthalmic Imaging, which gathered experts from around the world and across academia, government institutions, patient groups, and the private sector to discuss the opportunities and challenges of real-world implementation of AI in ophthalmic imaging for diagnosis and treatment in ophthalmology. Diseases addressed will include diabetic retinopathy, macular degeneration, retinopathy of prematurity, ocular oncology, and glaucoma. Key opinion leaders in the field will focus on addressing and harmonizing the key medical and regulatory foundational principles including safety and efficacy, with other important requirements including ethics, and handling protected health and personal identifiable information (PHI and PII) in the rapidly evolving information age.

Sincerely,

The 2022 CCOI Executive Committee

Mark Blumenkranz, MD – Byers Eye Institute at Stanford University School of Medicine
Malvina Eydelman, MD – FDA - CDRH
Michael Abramoff, MD, PhD – University of Iowa School of Medicine
Emily Chew, MD – National Eye Institute
Michael Chiang, MD – Director, National Eye Institute
Aaron Lee, MD – University of Washington
David Myung, MD, PhD – Byers Eye Institute at Stanford University School of Medicine
Michael Repka, MD – Wilmer Eye Institute, Johns Hopkins University School of Medicine
Joel Schuman, MD – NYU Langone School of Medicine
Carol Shields, MD – Wills Eye Hospital at Thomas Jefferson University
Michelle Tarver, MD, PhD – FDA/CDRH
Collaborative Community on Ophthalmic Imaging

CCOI APPRECIATES THE GENEROUS CONTRIBUTION OF OUR SPONSORS

GOLD-LEVEL SPONSOR

SILVER-LEVEL SPONSOR

CONTRIBUTOR-LEVEL SPONSOR